GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Microbot Medical Inc (FRA:CY9D) » Definitions » Float Percentage Of Total Shares Outstanding

Microbot Medical (FRA:CY9D) Float Percentage Of Total Shares Outstanding : 99.62% (As of May. 14, 2025)


View and export this data going back to . Start your Free Trial

What is Microbot Medical Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Microbot Medical's float shares is 36.14 Mil. Microbot Medical's total shares outstanding is 36.28 Mil. Microbot Medical's float percentage of total shares outstanding is 99.62%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Microbot Medical's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Microbot Medical's Institutional Ownership is 3.52%.


Microbot Medical Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Microbot Medical's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=36.14/36.28
=99.62%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Microbot Medical Business Description

Industry
Traded in Other Exchanges
Address
175 Derby Street, Bld 27, Hingham, MA, USA, 02043
Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.

Microbot Medical Headlines

No Headlines